IL10 and inflammatory bowel disease: To further demonstrate the importance of the lymphatic vasculature in IBD, VEGFR-3 blockade in IL-10 deficient mice led to a significant increase in disease severity with increased inflammation, impaired lymphatic function and morphology along with oedema in the colon [98].